Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study.
Heiligenstein JH, Hoog SL, Wagner KD, Findling RL, Galil N, Kaplan S, Busner J, Nilsson ME, Brown EB, Jacobson JG. Heiligenstein JH, et al. Among authors: jacobson jg. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):207-17. doi: 10.1089/cap.2006.16.207. J Child Adolesc Psychopharmacol. 2006. PMID: 16553541 Clinical Trial.
Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Study Team. Geller DA, et al. Among authors: jacobson jg. J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9. doi: 10.1097/00004583-200107000-00011. J Am Acad Child Adolesc Psychiatry. 2001. PMID: 11437015 Clinical Trial.
Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials.
Hoffmann VP, Case M, Stauffer VL, Jacobson JG, Conley RR. Hoffmann VP, et al. Among authors: jacobson jg. J Clin Psychopharmacol. 2010 Dec;30(6):656-60. doi: 10.1097/jcp.0b013e3181faf670. J Clin Psychopharmacol. 2010. PMID: 21105275 Clinical Trial.
59 results